{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:01:36Z","timestamp":1794322896297,"version":"4.9.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.118026","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T22:22:06Z","timestamp":1743546126000},"page":"118026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Dapansutrile mitigates concanavalin A- induced autoimmune hepatitis: Involvement of NLRP3\/IL-1\u03b2 and JNK\/ p38 MAPK pathways"],"prefix":"10.1016","volume":"186","author":[{"given":"Fahad O.","family":"Alenezi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar A.","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia H.","family":"El-Kashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa E.","family":"Abdelmageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118026_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.flm.2018.03.002","article-title":"The pathogenesis of autoimmune hepatitis","volume":"2","author":"Wang","year":"2018","journal-title":"Front. Lab. Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.118026_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","article-title":"Autoimmmune hepatitis","volume":"19","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.118026_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746436","article-title":"Dysfunctional immune regulation in autoimmune hepatitis: from pathogenesis to novel therapies","volume":"12","author":"Vuerich","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118026_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1091581819898399","article-title":"Beyond metabolism: role of the immune system in hepatic toxicity","volume":"39","author":"Hastings","year":"2020","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.biopha.2025.118026_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1201583","article-title":"A new cirrhotic animal protocol combining carbon tetrachloride with methotrexate to address limitations of the currently used chemical-induced models","volume":"14","author":"Mansouri","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118026_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41423-020-00580-w","article-title":"Immunopathobiology and therapeutic targets related to cytokines in liver diseases","volume":"18","author":"He","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.118026_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.09.004","article-title":"Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity","volume":"124","author":"Gupta","year":"2019","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.biopha.2025.118026_bib8","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/ph15111436","article-title":"Fasudil ameliorates methotrexate-induced hepatotoxicity by modulation of redox-sensitive signals","volume":"15","author":"Aboubakr","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.biopha.2025.118026_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118026_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118026_bib11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.biopha.2025.118026_bib12","article-title":"NLRP3 inflammasome and pyroptosis in liver pathophysiology: the emerging relevance of Nrf2 inducers","volume":"11","author":"Hurtado-Navarro","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.biopha.2025.118026_bib13","article-title":"The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment","volume":"13","author":"Yu","year":"2022","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118026_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12964-022-00972-7","article-title":"Concanavalin A as a promising lectin-based anti-cancer agent: the molecular mechanisms and therapeutic potential","volume":"20","author":"Huldani","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.biopha.2025.118026_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/biol-2022-0013","article-title":"Concanavalin A-induced autoimmune hepatitis model in mice: Mechanisms and future outlook","volume":"17","author":"Liu","year":"2022","journal-title":"Open Life Sci."},{"key":"10.1016\/j.biopha.2025.118026_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152544","article-title":"Macrophage-derived extracellular vesicles regulate concanavalin A-induced hepatitis by suppressing macrophage cytokine production","volume":"443","author":"Kawata","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2025.118026_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108411","article-title":"Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice","volume":"102","author":"Hao","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118026_bib18","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/08923973.2022.2093741","article-title":"Gastrodin ameliorates Concanavalin A-induced acute hepatitis via the IL6\/JAK2\/STAT3 pathway","volume":"44","author":"Zhou","year":"2022","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"1_","key":"10.1016\/j.biopha.2025.118026_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0023677215572841","article-title":"The concanavalin A model of acute hepatitis in mice","volume":"49","author":"Heymann","year":"2015","journal-title":"Lab. Anim."},{"issue":"5","key":"10.1016\/j.biopha.2025.118026_bib20","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118026_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","article-title":"Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral nlrp3 inhibitor dapansutrile in subjects with nyha ii\u2013iii systolic heart failure","volume":"77","author":"Wohlford","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118026_bib22","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.biopha.2025.118026_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.903834","article-title":"The Nlrp3 inflammasome inhibitor dapansutrile attenuates cyclophosphamide-induced interstitial cystitis","volume":"13","author":"Kiran","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118026_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109825","article-title":"The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2\/ROS\/NLRP3\/Caspase-1-dependent IL-1\u03b2 and IL-18 secretion","volume":"77","author":"Sukhanov","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biopha.2025.118026_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.990469","article-title":"Exploring the mechanism of action of dapansutrile in the treatment of gouty arthritis based on molecular docking and molecular dynamics","volume":"13","author":"Cao","year":"2022","journal-title":"Front. Physiol."},{"issue":"15","key":"10.1016\/j.biopha.2025.118026_bib26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.21037\/atm-21-378","article-title":"Daidzein ameliorated concanavalin A-induced liver injury through the Akt\/GSK-3\u03b2\/Nrf2 pathway in mice","volume":"9","author":"Li","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118026_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0000000000000658","article-title":"The NLRP3 inflammasome inhibitor, OLT1177 (Dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the mouse","volume":"73","author":"Toldo","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118026_bib28","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"10.1016\/j.biopha.2025.118026_bib29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/17474124.2021.1949289","article-title":"Chronic liver disease and oxidative stress - a narrative review","volume":"15","author":"Seen","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.biopha.2025.118026_bib30","doi-asserted-by":"crossref","unstructured":"A.J.J.Dd Czaja, sciences, Nature and implications of oxidative and nitrosative stresses in autoimmune hepatitis, 61 (2016) 2784-2803.","DOI":"10.1007\/s10620-016-4247-6"},{"key":"10.1016\/j.biopha.2025.118026_bib31","series-title":"Seminars in liver disease","first-page":"186","article-title":"The role of inflammation in cholestasis: clinical and basic aspects","author":"Kosters","year":"2010"},{"key":"10.1016\/j.biopha.2025.118026_bib32","doi-asserted-by":"crossref","DOI":"10.5376\/cmb.2016.06.0001","article-title":"NFkB pathway and inhibition: an overview","author":"Biswas","year":"2016","journal-title":"Comput. Mol. Biol. 6"},{"issue":"2","key":"10.1016\/j.biopha.2025.118026_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/alcalc\/agw098","article-title":"The role of NFkB in drug addiction: beyond inflammation","volume":"52","author":"Nennig","year":"2017","journal-title":"Alcohol. Alcohol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118026_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jat.1393","article-title":"NF-\u03baB in liver diseases: a target for drug therapy","volume":"29","author":"Muriel","year":"2009","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.biopha.2025.118026_bib35","doi-asserted-by":"crossref","unstructured":"S. Papa, C. Bubici, F. Zazzeroni, G. Franzoso, Mechanisms of liver disease: cross-talk between the NF-\u03baB and JNK pathways, (2009).","DOI":"10.1515\/BC.2009.111"},{"issue":"48","key":"10.1016\/j.biopha.2025.118026_bib36","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1038\/onc.2008.300","article-title":"NF-\u03baB signaling, liver disease and hepatoprotective agents","volume":"27","author":"Sun","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.118026_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-008-8091-0","article-title":"Inflammatory pathways in liver homeostasis and liver injury","volume":"36","author":"Tacke","year":"2009","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.biopha.2025.118026_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106137","article-title":"Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-\u03baB and MAPK signaling","volume":"80","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118026_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17474124.2022.2020642","article-title":"The role and function of CD4+ T cells in hepatic ischemia-reperfusion injury","volume":"16","author":"Wang","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.biopha.2025.118026_bib40","doi-asserted-by":"crossref","unstructured":"C. Zheng, S. Yin, Y. Yang, Y. Yu, X.J.C. Xie, M. Immunology, CD24 aggravates acute liver injury in autoimmune hepatitis by promoting IFN-\u03b3 production by CD4+\u2009T cells, 15(3) (2018) 260-271.","DOI":"10.1038\/cmi.2016.57"},{"issue":"22","key":"10.1016\/j.biopha.2025.118026_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214009","article-title":"Hepatocyte DAX1 deletion exacerbates inflammatory liver injury by inducing the recruitment of CD4(+) and CD8(+) T cells through NF-\u03baB p65 signaling pathway in mice","volume":"23","author":"Yun","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biopha.2025.118026_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jare.2021.03.014","article-title":"Spred2 controls the severity of Concanavalin A-induced liver damage by limiting interferon-gamma production by CD4+\u2009and CD8+\u2009T cells","volume":"35","author":"Sun","year":"2022","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118026_bib43","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1159\/000373971","article-title":"Emodin protects against concanavalin A-induced hepatitis in mice through inhibiting activation of the p38 MAPK-NF-\u03baB signaling pathway","volume":"35","author":"Xue","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.biopha.2025.118026_bib44","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.4049\/jimmunol.160.8.3759","article-title":"Differential capacities of CD4+, CD8+, and CD4\u2212 CD8\u2212 T cell subsets to express IL-18 receptor and produce IFN-\u03b3 in response to IL-18","volume":"160","author":"Tomura","year":"1998","journal-title":"J. Immunol."},{"issue":"5553","key":"10.1016\/j.biopha.2025.118026_bib45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1126\/science.1065543","article-title":"Distinct effects of T-bet in TH1 lineage commitment and IFN-\u03b3 production in CD4 and CD8 T cells","volume":"295","author":"Szabo","year":"2002","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biopha.2025.118026_bib46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0168-8278(99)80334-1","article-title":"Elevated intracellular IFN-\u03b3 levels in circulating CD8+\u2009lymphocytes in patients with fulminant hepatitis","volume":"31","author":"Kimura","year":"1999","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118026_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0016-5085(97)70235-X","article-title":"Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections","volume":"112","author":"Bertoletti","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2025.118026_bib48","doi-asserted-by":"crossref","unstructured":"N. Kelley, D. Jeltema, Y. Duan, Y.J.Ijoms He, The NLRP3 inflammasome: an overview of mechanisms of activation and regulation, 20(13) (2019) 3328.","DOI":"10.3390\/ijms20133328"},{"issue":"9","key":"10.1016\/j.biopha.2025.118026_bib49","first-page":"2114","article-title":"m. immunology, NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021"},{"key":"10.1016\/j.biopha.2025.118026_bib50","doi-asserted-by":"crossref","unstructured":"J. Fu, H.J.Aroi Wu, Structural mechanisms of NLRP3 inflammasome assembly and activation, 41(1) (2023) 301-316.","DOI":"10.1146\/annurev-immunol-081022-021207"},{"issue":"11","key":"10.1016\/j.biopha.2025.118026_bib51","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3724\/abbs.2022137","article-title":"NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease","volume":"54","author":"Guan","year":"2022","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.biopha.2025.118026_bib52","doi-asserted-by":"crossref","unstructured":"Y. Kang, X. Kuang, H. Yan, P. Ren, X. Yang, H. Liu, Q. Liu, H. Yang, X. Kang, X.J.M. Shen, A novel synbiotic alleviates autoimmune hepatitis by modulating the gut microbiota-liver axis and inhibiting the hepatic TLR4\/NF-\u03baB\/NLRP3 signaling pathway, 8(2) (2023) e01127-22.","DOI":"10.1128\/msystems.01127-22"},{"key":"10.1016\/j.biopha.2025.118026_bib53","doi-asserted-by":"crossref","unstructured":"A. Abderrazak, T. Syrovets, D. Couchie, K.El Hadri, B. Friguet, T. Simmet, M.J.Rb Rouis, NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases, 4 (2015) 296-307.","DOI":"10.1016\/j.redox.2015.01.008"},{"issue":"12","key":"10.1016\/j.biopha.2025.118026_bib54","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2025.118026_bib55","doi-asserted-by":"crossref","unstructured":"P.R. Nunes, S.V. Mattioli, V.C.J.C. Sandrim, NLRP3 activation and its relationship to endothelial dysfunction and oxidative stress: implications for preeclampsia and pharmacological interventions, 10(11) (2021) 2828.","DOI":"10.3390\/cells10112828"},{"issue":"1","key":"10.1016\/j.biopha.2025.118026_bib56","article-title":"Astragaloside IV suppresses high glucose-induced NLRP3 inflammasome activation by inhibiting TLR4\/NF-\u03baB and CaSR","volume":"2019","author":"Leng","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2025.118026_bib57","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3389\/fimmu.2019.02578","article-title":"OLT1177 (Dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis","volume":"10","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118026_bib58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.intimp.2016.03.023","article-title":"Alpha-lipoic acid protects mice against concanavalin A-induced hepatitis by modulating cytokine secretion and reducing reactive oxygen species generation","volume":"35","author":"Fei","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2025.118026_bib59","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00210-017-1410-3","article-title":"Propolis alleviates concanavalin A-induced hepatitis by modulating cytokine secretion and inhibition of reactive oxygen species","volume":"390","author":"Mounieb","year":"2017","journal-title":"Naunyn-Schmiede 'S. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118026_bib60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2015.12.080","article-title":"Methane-rich saline protects against concanavalin A-induced autoimmune hepatitis in mice through anti-inflammatory and anti-oxidative pathways","volume":"470","author":"He","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.118026_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119123","article-title":"BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R\/NLRP3 and MyD88\/NF-\u03baB signaling in DSS-induced colitis in rats","volume":"270","author":"Saber","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118026_bib62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hlc.2023.09.017","article-title":"Dapansutrile ameliorates atrial inflammation and vulnerability to atrial fibrillation in HFpEF rats","volume":"33","author":"Yang","year":"2024","journal-title":"Heart, Lung Circ."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:56:18Z","timestamp":1781823378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":62,"alternative-id":["S0753332225002203"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118026","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapansutrile mitigates concanavalin A- induced autoimmune hepatitis: Involvement of NLRP3\/IL-1\u03b2 and JNK\/ p38 MAPK pathways","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118026"}}